Intercalation modification of FeOCl and its application in dye wastewater treatment

The textile industry spreads globally with the challenges of its wastewater treatment,especially dyes,which are difficult to degrade.To improve coagulation-flocculation process in dye wastewater treatment,an intercalation process was employed to prepare a new efficient coagulant of lithium borohydride-iron oxychloride(LiBH_(4)_FeOCl) in this study.The layered crystal pristine iron oxychloride(FeOCl) material was prepared by chemical gas phase migration.LiBH4 was introduced into the layers of two dimensional(2 D) FeOCl nanosheets by a simple method of liquid phase insertion.The samples were characterized by a field emitting scanning electron microscopy(SEM),a rotating anode X-ray powder diffractometer(XRD),etc.The cationic dye was employed as the simulated pollutant.A coagulation and decolorization experimental device was built to study the coagulation performance of the new coagulant LiBH_(4)_FeOCl.It is found that the intercalation modified LiBH_(4)_FeOCl exhibits the characteristics of crystal structure,and the layered structure of FeOCl is preserved.LiBH_(4)_FeOCl,as an insoluble inorganic solid coagulant,performs well for dye pollutants of methyl red,basic yellow 1,methylene blue,rhodamine B,ethyl violet and Janus green B.The reaction rate is significantly 68% higher than the current commercial coagulants of Al_(2)(SO_(4))_(3).The mechanism analysis reveals that LiBH_(4)_FeOCl breaks and disperses rapidly in the water environment.Its negatively charged material particles can be electrostatically adsorbed with dye pollutant molecules through electrostatic action.The above collaborative actions of breaking,dispersion and electrostatic adsorption are the main coagulation mechanisms of LiBH_(4)_FeOCl.The solid inorganic coagulant of LiBH4FeOCl provides a competitive alternative for traditional inorganic salts and organic coagulants.

Significant Inhibition of Porcine Epidemic Diarrhea Virus In Vitro by Remdesivir,Its Parent Nucleoside and β-D-N^(4)-hydroxycytidine

Porcine epidemic diarrhea(PED)caused by porcine epidemic diarrhea virus(PEDV)is widespread in the world.In recent years,the increased virulence of the virus due to viral variations,has caused great economic losses to the pig industry in many countries.It is always worthy to find effective therapeutic methods for PED.As an important class of antivirals,nucleoside drugs which target viral polymerases have been applied in treating human viral infections for half a century.Herein,we evaluated the anti-PEDV potential of three broad-spectrum antiviral nucleoside analogs,remdesivir(RDV),its parent nucleoside(RDV-N)andβ-D-N^(4)-hydroxycytidine(NHC).Among them,RDV-N was the most active agent in Vero E6 cells with EC_(50) of 0.31μmol/L,and more potent than RDV(EC_(50)=0.74μmol/L)and NHC(EC_(50)=1.17μmol/L).The activity of RDV-N was further confirmed using an indirect immuno-fluorescence assay.Moreover,RDV-N exhibited a good safety profile in cells and in mice.The high sequence similarity of the polymerase functional domains of PEDV with other five porcine coronaviruses indicated a broader antiviral spectrum for the three compounds.Generally,RDV-N is a promising broad-spectrum antiviral nucleoside,and it would be worthy to make some structural modifications to increse its oral bioavailability.